(Rare) good news when it comes to #AMR
RT @GSK: #NEWS for #investors and #media: We’ve announced that two of our phase III trials for our antibiotic candidate will be stopped early for efficacy.

Learn more: https://www.gsk.com/en-gb/

🐦🔗: https://nitter.eu/sara_saracerdas/status/1588507635456049152